BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31814158)

  • 1. Assessing predictive accuracy of survival regressions subject to nonindependent censoring.
    Wang M; Long Q; Chen C; Zhang L
    Stat Med; 2020 Feb; 39(4):469-480. PubMed ID: 31814158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic.
    Wang M; Long Q
    Biometrics; 2016 Sep; 72(3):897-906. PubMed ID: 26756274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reweighted estimators for additive hazard model with censoring indicators missing at random.
    Chen X; Cai J
    Lifetime Data Anal; 2018 Apr; 24(2):224-249. PubMed ID: 28766089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression with a right-censored predictor using inverse probability weighting methods.
    Matsouaka RA; Atem FD
    Stat Med; 2020 Nov; 39(27):4001-4015. PubMed ID: 32779274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression analysis of multivariate interval-censored failure time data with informative censoring.
    Yu M; Feng Y; Duan R; Sun J
    Stat Methods Med Res; 2022 Mar; 31(3):391-403. PubMed ID: 34878352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable selection using inverse probability of censoring weighting.
    Kojima M
    Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of integrated transition hazards and stage occupation probabilities for non-Markov systems under dependent censoring.
    Datta S; Satten GA
    Biometrics; 2002 Dec; 58(4):792-802. PubMed ID: 12495133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.
    Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression analysis of case K interval-censored failure time data in the presence of informative censoring.
    Wang P; Zhao H; Sun J
    Biometrics; 2016 Dec; 72(4):1103-1112. PubMed ID: 27123560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction accuracy for the cure probabilities in mixture cure models.
    Jiang W; Sun H; Peng Y
    Stat Methods Med Res; 2017 Oct; 26(5):2029-2041. PubMed ID: 28523948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imputation methods for informative censoring in survival analysis with time dependent covariates.
    Jin M
    Contemp Clin Trials; 2024 Jan; 136():107401. PubMed ID: 37995968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of baseline covariate adjustment methods for restricted mean survival time.
    Hanada K; Moriya J; Kojima M
    Contemp Clin Trials; 2024 Mar; 138():107440. PubMed ID: 38228232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.